Autopsy report · NCT02946372

Evaluation of a New Surgical Technique for Macular Hole Which Was Not Closed After a Previous Surgery

“Principal investigator left the institution”

The sponsor’s own words in the registry.

Life of this trial

• Ran for about 7 months before it stopped.
• 16 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Na

Sponsor

Groupe Hospitalier de la Region de Mulhouse et Sud Alsace

Sponsor type

University, hospital or other

Conditions

Retinal Perforations

Interventions

internal limiting membrane transplantation (ILMT)

Participants

16

Sites

1

Countries

France

Trials that died the same way

• Detailed Clinical, Biochemical and Genetic Characterization in Gonadotropin-releasing Hormone (GnRH) Deficiency Disorders
  “the Principal Investigator left the institution” (98% match in meaning)
• Gliadel Wafer, Temozolomide and Radiation Therapy for Newly Diagnosed GBM
  “Principal Investigator has left the institution” (98% match in meaning)
• Prevention of Disease Progression in Early Stage Indolent B Cell Malignancies. (SMM)
  “Original Principal Investigator left the institution.” (96% match in meaning)
• Prepectoral vs Partial Subpectoral Two-Stage Implant-Based Breast Reconstruction
  “Principal Investigator left institution” (95% match in meaning)
• Melphalan on Disease Burden Measured by Next Generation Sequencing Before AHCT (Autologous Hematopoietic Cell Transplant) for Multiple Myeloma
  “The original principal Investigator left the institution.” (95% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.